DNA damage and nitric oxide synthesis in experimentally infected Balb/c mice with Trypanosoma cruzi

Daniel A Ribeiro1, Sueli A Calvi, Mariele M Picka

  • 1Department Health Sciences, Federal University of Sao Paulo, UNIFESP, SP, Brazil. daribeiro@unifesp.br

Experimental Parasitology
|February 9, 2007
PubMed

Insights

Experimental Chagas disease causes DNA damage in mice heart and spleen cells, likely via nitric oxide. Benznidazole therapy partially reduced these genotoxic effects in spleen cells.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Toxicology

Background:

  • Chagas disease, caused by Trypanosoma cruzi, is a significant global health concern.
  • Understanding the genotoxic effects of T. cruzi infection and the protective role of benznidazole is crucial for treatment strategies.

Purpose of the Study:

  • To investigate DNA damage in various organs of mice with experimental Chagas disease.
  • To assess the impact of benznidazole therapy on T. cruzi-induced genotoxicity.
  • To explore the role of nitric oxide synthesis in Chagas disease-associated DNA damage.

Main Methods:

  • Experimental infection of Balb/c mice with Trypanosoma cruzi.
  • Administration of benznidazole therapy to infected mice.
  • Evaluation of DNA damage using the single cell gel (comet) assay.
  • Measurement of nitric oxide synthesis in spleen cells.

Main Results:

  • Trypanosoma cruzi infection induced DNA damage in heart and spleen cells.
  • Increased DNA lesions were observed in spleen cells of infected mice.
  • Nitric oxide synthesis was significantly elevated in infected mice, particularly in the T. cruzi infected group.
  • Benznidazole therapy showed a protective effect, minimizing T. cruzi-induced genotoxicity in spleen cells.

Conclusions:

  • Trypanosoma cruzi infection can lead to increased DNA damage in mice heart and spleen.
  • Nitric oxide likely plays a role in the DNA damaging effects of T. cruzi.
  • Benznidazole therapy demonstrates potential in mitigating the genotoxic impact of Chagas disease in spleen cells.